Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vesicoureteral reflux.

Larry A Greenbaum1, Hrair-George O Mesrobian

  • 1Division of Pediatric Nephrology, Emory University School of Medicine, Children's Healthcare of Atlanta, 2015 Uppergate Drive NE, Atlanta, GA 30322, USA. Lary_Greenbaum@oz.ped.emory.edu

Pediatric Clinics of North America
|May 24, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pegcetacoplan for Adolescents with C3 Glomerulopathy or Primary Immune Complex Membranoproliferative GN: Phase 3 VALIANT Subgroup Analysis.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Ten tips on how to optimize nutrition in children with chronic kidney disease or on dialysis.

Clinical kidney journal·2026
Same author

Hyperkalemia in pediatric nephrectomy: a common complication.

Pediatric nephrology (Berlin, Germany)·2026
Same author

Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN.

The New England journal of medicine·2025
Same author

The dietary management of sodium in children with kidney diseases-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce.

Pediatric nephrology (Berlin, Germany)·2025
Same author

Steroid-sparing drugs in children and young adults with nephrotic syndrome: a target trial emulation.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2025
Same journal

Barriers, Breakthroughs, and the Future of Pediatric Dermatologic Care.

Pediatric clinics of North America·2026
Same journal

Advancing Pediatric Dermatology: Innovations in Care and Access.

Pediatric clinics of North America·2026
Same journal

No Child Left Behind: Advancing Access in Pediatric Dermatology, a 4-Year, Single-Center Experience.

Pediatric clinics of North America·2026
Same journal

Telemedicine and Access to Pediatric Dermatology Care.

Pediatric clinics of North America·2026
Same journal

Inequitable Reimbursement for Pediatric Providers: A Review of Structural Factors that Disincentivize the Care of Children.

Pediatric clinics of North America·2026
Same journal

Medical Photography's Power to Change Medical Care.

Pediatric clinics of North America·2026
See all related articles

Vesicoureteral reflux, a common congenital anomaly in children, involves urine flowing backward into the ureter. Understanding its links to infections and kidney damage is crucial for effective management strategies.

Area of Science:

  • Pediatric Urology
  • Congenital Anomalies
  • Nephrology

Background:

  • Vesicoureteral reflux is a frequent congenital anomaly in pediatric patients.
  • It is characterized by the abnormal retrograde flow of urine from the bladder to the ureter.
  • This condition is clinically significant due to its association with urinary tract infections and renal scarring.

Purpose of the Study:

  • To review current understanding of vesicoureteral reflux pathogenesis.
  • To discuss evolving surgical techniques for managing this condition.
  • To highlight the clinical implications of reflux, infection, and renal damage.

Main Methods:

  • Literature review of recent advancements in understanding vesicoureteral reflux.
  • Analysis of new and established surgical interventions.

Related Experiment Videos

  • Synthesis of clinical data on associated complications.
  • Main Results:

    • New insights into the pathogenesis of vesicoureteral reflux have emerged.
    • Novel surgical techniques are being developed and refined.
    • The clinical management approach is adapting to these advancements.

    Conclusions:

    • Vesicoureteral reflux management is evolving with new pathogenetic insights and surgical options.
    • Early detection and appropriate intervention are key to preventing renal damage.
    • Continued research is vital for optimizing pediatric urological care.